ACR 3518

ACR 3518

Phase I Safety Assessment of Hypofractionated Postoperative Radiotherapy (H-PORT) for Intermediate-Risk Head and Neck Cancer

Principal Investigator

Etta Pisano, MD

Primary Objective

To determine if a hypofractionated postoperative radiotherapy (H-PORT) schedule for patients with intermediate-risk head and neck cancer (squamous cell carcinoma of the oral cavity, oropharynx, or larynx) who have undergone surgery is safe and feasible for further evaluation in a phase II clinical trial

Patient Population

Head and Neck; Patients with intermediate-risk head and neck cancer (squamous cell carcinoma of the oral cavity, oropharynx, or larynx)

Study Information

This trial is sponsored by the American College of Radiology in collaboration with RTOG Foundation and funded by the Pennsylvania Department of Health Commonwealth Universal Research Enhancement Program (PA CURE). The trial is open to institutions in Pennsylvania.